Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Milestone Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 25.00 and a low estimate of 2.00. The median estimate represents a 351.61% increase from the last price of 1.55.
High | 1,512.9% | 25.00 |
Med | 351.6% | 7.00 |
Low | 29.0% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | +20.42% |
Average growth rate | +13.85% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -48.89% |
More ▼